From: Quality and continuity of information between primary care physicians and rheumatologists
RA n = 120 | IA, other n = 167 | Crystal n = 122 | PMR n = 66 | SpA n = 76 | PsA n = 44 | Other SARDsa n = 150 | |
---|---|---|---|---|---|---|---|
Anatomical Site(s) | 71.7% | 71.3% | 68.0% | 31.8% | 57.9% | 77.3% | 36.0% |
Joint Pain | 64.2% | 68.9% | 56.6% | 24.2% | 60.5% | 56.8% | 24.0% |
Symptom duration | 52.5% | 44.3% | 31.1% | 39.4% | 32.9% | 38.6% | 36.7% |
Swollen joints | 49.2% | 42.5% | 39.3% | NR | 15.8% | 52.3% | 16.7% |
“Arthritis” | 26.7% | 15.6% | 16.4% | NR | 9.2% | 22.7% | 4.0% |
Morning stiffness | 18.3% | 15.0% | NR | 12.1% | 18.4% | 15.9% | 4.0% |
Impaired abilities with daily living | 8.3% | 4.8% | 6.6% | 10.6% | NR | NR | 4.7% |
Generalized pain | 6.7% | 15.6% | NR | 48.5% | 14.5% | NR | 18.7% |
Deformed joints | 5.8% | NR | NR | NR | NR | NR | NR |
Rash(es) | NR | 4.2% | NR | NR | NR | NR | 20.7% |
Raynaud’s | NR | NR | NR | NR | NR | NR | 18.7% |
Fatigue | NR | 3.6% | NR | NR | NR | NR | 10.0% |